These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 717407)

  • 41. Clinical considerations and costs associated with formulary conversion from tobramycin to gentamicin.
    Green ER; Chrymko MM; Rozek SL; Kitrenos JG
    Am J Hosp Pharm; 1989 Apr; 46(4):714-9. PubMed ID: 2719049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
    Coppola P
    Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic review performed by a pharmacy and therapeutics subcommittee.
    Klapp DL; Ramphal R
    QRB Qual Rev Bull; 1982 Jan; 8(1):15-9. PubMed ID: 6803205
    [No Abstract]   [Full Text] [Related]  

  • 44. Computer-assisted antimicrobial-use monitoring.
    Inaraja MT; Paloma JM; Giráldez J; Idoate AJ; Hualde S
    Am J Hosp Pharm; 1986 Mar; 43(3):664-70. PubMed ID: 3754692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of parenteral cephalosporin regulation on pharmacy costs.
    Ryan JL; Francese J
    Hosp Formul; 1983 May; 18(5):510-2. PubMed ID: 10260198
    [No Abstract]   [Full Text] [Related]  

  • 46. Reducing the number of formulary theophylline preparations.
    Anandan JV
    Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An approach to cost-effective antibiotic utilization.
    Venezio FR; Waitley DW
    Hosp Formul; 1988 Dec; 23 Suppl D():32-5. PubMed ID: 10312796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a P & T committee newsletter on anti-infective prescribing habits.
    Lyon RA; Norvell MJ
    Hosp Formul; 1985 Jun; 20(6):742-4. PubMed ID: 10271477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacy and Therapeutics committee. Cost-containment considerations.
    Hochla PK; Tuason VB
    Arch Intern Med; 1992 Sep; 152(9):1773-5. PubMed ID: 1520043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
    Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restricted cephalosporin use in teaching hospitals.
    Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1981 Apr; 38(4):513-7. PubMed ID: 7282677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost effectiveness of an enteral products formulary.
    Durfee DD; Skinner-Domet VM
    Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experience with a two-tiered therapeutic interchange policy.
    Rich DS
    Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a targeted antibiotic advisory consult program on hospital antibiotic costs.
    Murray MD; Kohler RB; Main JW
    Hosp Formul; 1988 Jun; 23(6):518-24, 529-30. PubMed ID: 10287850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modifying empiric antibiotic prescribing: experience with one strategy in a medical residency program.
    MacCosbe PE; Gartenberg G
    Hosp Formul; 1985 Sep; 20(9):986-8, 993-5, 999. PubMed ID: 10274168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.